AVKARE Inc. recalls AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.
Recalled September 18, 2019 · FDA recall D-1875-2019 · AVKARE
Hazard
Failed Stability Specifications. · FDA Class II
Units
5953 bottles
Sold at
Nationwide in the U.S.
Description
Failed Stability Specifications.
Product
AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.
Manufacturer(s)
AVKARE Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →